- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Alpha Tau: Patientenrekrutierung für zulassungsrelevante Hautkrebs-Studie abgeschlossen | 2 | Investing.com Deutsch | ||
| Fr | Alpha Tau completes enrollment in U.S. skin cancer pivotal trial | 1 | Investing.com | ||
| Fr | Alpha Tau Medical Ltd.: Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT to Treat Recurrent Cutaneous Squamous Cell Carcinoma | 355 | GlobeNewswire (Europe) | - First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA pre-market approval (PMA); Company has already initiated... ► Artikel lesen | |
| Do | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT at the University of Verona's Pancreas Institute | 2 | GlobeNewswire (USA) | ||
| 04.05. | Alpha Tau reports disease control in pancreatic cancer trial | 3 | Investing.com | ||
| 04.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT Pancreatic Cancer Trials Presented at DDW 2026 | 1 | GlobeNewswire (USA) | ||
| 04.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.04. | Alpha Tau: Abstract zu Bauchspeicheldrüsenkrebs für ASCO-Jahrestagung angenommen | 2 | Investing.com Deutsch | ||
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.04. | Alpha Tau abstract accepted at ASCO annual meeting in May | 2 | Investing.com | ||
| 27.04. | Alpha Tau Medical Ltd.: Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies | 1 | GlobeNewswire (USA) | ||
| 27.04. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on FDA approval | 1 | Investing.com | ||
| 23.04. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT in French Multicenter ACAPELLA Clinical Trial | 161 | GlobeNewswire (Europe) | ACAPELLA is the European multicenter clinical trial evaluating Alpha DaRT alpha-emitter radiotherapeutics combined with capecitabine for inoperable LAPC patients who have completed first-line mFOLFIRINOX... ► Artikel lesen | |
| 23.04. | Alpha Tau Medical Ltd.: Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane (Nab-Paclitaxel) | 175 | GlobeNewswire (Europe) | - IDE supplement expands trial to the other primary standard-of-care chemotherapy for pancreatic cancer patients, alongside mFOLFIRINOX - - IDE supplement also expands total trial size from 30 to... ► Artikel lesen | |
| 23.04. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 31.03. | Alpha Tau Medical Ltd.: Alpha Tau Announces First-Ever Oral Presentation of Alpha DaRT Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026 | 4 | GlobeNewswire (USA) | ||
| 31.03. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 09.03. | Alpha Tau Medical GAAP EPS of -$0.42 | 1 | Seeking Alpha | ||
| 09.03. | Alpha Tau Medical Ltd. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 09.03. | Alpha Tau Medical Ltd.: Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update | 2.212 | GlobeNewswire (Europe) | - Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium... ► Artikel lesen | |
| 09.03. | Alpha Tau Medical Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 40,280 | -1,13 % | EQS-News: Fresenius SE & Co. KGaA: Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt (News... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,680 | -0,26 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 54,82 | -0,02 % | BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results | ||
| PROGYNY | 23,725 | +0,02 % | Citizens raises Progyny stock price target on higher EBITDA outlook | ||
| SIEMENS HEALTHINEERS | 33,490 | -1,30 % | BARCLAYS stuft Siemens Healthineers auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Siemens Healthineers auf "Overweight" mit einem Kursziel von 55 Euro belassen. Hassan Al-Wakeel zog in einer... ► Artikel lesen | |
| GENEDX | 40,780 | +0,02 % | Cathie Wood's ARK sells AMD stock, buys Shopify and GeneDx | ||
| BILLIONTOONE | 93,10 | +0,15 % | Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know | ||
| ALIGNMENT HEALTHCARE | 17,920 | -0,06 % | Can Alignment Healthcare (ALHC) Climb 32.61% to Reach the Level Wall Street Analysts Expect? | ||
| GERRESHEIMER | 28,420 | +6,92 % | Aktionär Active Ownership erhöht Gerresheimer-Aktienbeteiligung leicht | DJ Aktionär Active Ownership erhöht Gerresheimer-Aktienbeteiligung leicht
DOW JONES--Der Luxemburger Investor Active Ownership hat seine Beteiligung bei Gerresheimer leicht aufgestockt. Wie aus... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,380 | +0,48 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 37,40 Euro auf "Underweight" belassen. Analyst David Adlington glich seine Schätzungen für den Dialysekonzern... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,220 | +5,00 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| CONCENTRA GROUP | 24,155 | +0,10 % | Concentra revises 2026 guidance to $2.275B-$2.375B revenue and $460M-$480M adjusted EBITDA | ||
| PROCEPT BIOROBOTICS | 25,380 | -0,08 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,040 | -0,09 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| ADAPTHEALTH | 11,300 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report |
Das Unternehmen ALPHA TAU MEDICAL LTD kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,035 (-0,41 %) liegt der Kurs bei 8,475 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.